about
Gout--current diagnosis and treatmentMicrowave Heating of Synthetic Skin Samples for Potential Treatment of Gout Using the Metal-Assisted and Microwave-Accelerated Decrystallization Technique.Elastic liposomal formulation for sustained delivery of colchicine: in vitro characterization and in vivo evaluation of anti-gout activitySerum urate is not associated with coronary artery calcification: the NHLBI Family Heart Study.Spondyloarthritis: a gouty display.Antioxidative phytochemicals from Rhododendron oldhamii Maxim. leaf extracts reduce serum uric acid levels in potassium oxonate-induced hyperuricemic mice.Digit-Threatening Severe Tophaceous Gout.Evaluation of Xanthine Oxidase Inhibitory Potential and In vivo Hypouricemic Activity of Dimocarpus longan Lour. ExtractsPhytochemicals from Tradescantia albiflora Kunth Extracts Reduce Serum Uric Acid Levels in Oxonate-induced Rats.Epidemiology of hyperuricemia in the elderly.Urinary L-type fatty acid-binding protein can reflect renal tubulointerstitial injury.Serum uric acid is associated with carotid plaques: the National Heart, Lung, and Blood Institute Family Heart Study.Dual-energy CT in gout - A review of current concepts and applications.Elastic liposomes as novel carriers: recent advances in drug delivery.Lesinurad: A significant advancement or just another addition to existing therapies of gout?Uric acid in plants and microorganisms: Biological applications and genetics - A review.Pyrazinamide-induced hyperuricemia.Febuxostat (Uloric), A New Treatment Option for Gout.Hypouricemic Effects of Ganoderma applanatum in Hyperuricemia Mice through OAT1 and GLUT9.Gout of hand and wrist: the value of US as compared with DECT.Transethosomal gels as carriers for the transdermal delivery of colchicine: statistical optimization, characterization, and ex vivo evaluation.Hypouricemic Effects of Extracts From Agrocybe aegerita on Hyperuricemia Mice and Virtual Prediction of Bioactives by Molecular Docking.Insights in Public Health: Hyperuricemia and Gout in Hawai'i.A review of antioxidant and pharmacological properties of phenolic compounds in
P2860
Q24644156-2A9F27B0-D994-4CE9-9E8A-0DBAE259EEEAQ30830332-B8979ADF-F30B-4A45-8927-EBF5940359F4Q33405288-7A05B70A-A39F-4F9D-A9E1-88BD6D479B3DQ35057848-F2504A28-7142-4B28-AF1F-7C34038E3D7DQ35829200-FCD4086B-AF5C-4049-95B3-1E7B4456E43AQ35858062-098F102A-CC75-4E92-BC3B-DB6CE20B43C6Q36910092-172A1243-D46A-43EE-8EFC-686475E518BAQ36942591-CFB389D0-E7C1-4D2C-9DA7-98638F04A44CQ36942603-F73B846A-A84B-418D-9ED2-6E0D5FFD5BD6Q36987274-49E3D8F7-FB21-4DA6-9F61-92AEB54B0673Q37164509-A95DE410-DC6A-4231-B0C4-915A36BD8E9AQ37317340-A0349F81-828E-46DD-B1A5-B84E6C5EA5D0Q37707121-F25D96D3-4E0D-4451-BE34-9E47472FB732Q38648991-AF4185B8-DF85-44F2-9317-A1E7437C0621Q39120827-790BDB51-2800-4371-90F3-1EBB90171A5DQ41026402-CAA7DD53-36FE-4152-9FB5-DFE8015AF45DQ41779052-66A85200-E40A-4448-8203-79272868DADCQ47122811-4131BABB-D220-4B4C-A87B-452835D24AFEQ47696723-73ABAC7F-3D39-4A87-AEA1-A867944D1D6DQ52573246-6FB81692-AF87-4FAB-9F1F-0A062F3B6C47Q53407444-63C1DA80-5FD4-4905-9A3E-73BE50C30070Q54958004-779D1591-93CC-4CA8-BCD6-26C1FE5C7765Q55394775-28B8C559-BB69-4C76-A476-0094FD48AA76Q57301216-213D3EB8-EE0D-4F65-9AC1-359F76875056
P2860
description
1999 nî lūn-bûn
@nan
1999 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Gout and hyperuricemia.
@ast
Gout and hyperuricemia.
@en
type
label
Gout and hyperuricemia.
@ast
Gout and hyperuricemia.
@en
prefLabel
Gout and hyperuricemia.
@ast
Gout and hyperuricemia.
@en
P2093
P1476
Gout and hyperuricemia
@en
P2093
P304
P577
1999-02-01T00:00:00Z